Compare ImmunityBio Inc. Common Stock (IBRX) vs Hyperliquid Strategies Inc Common Stock (PURR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ImmunityBio Inc. Common Stock vs Hyperliquid Strategies Inc Common Stock — how do they compare? ImmunityBio Inc. Common Stock trades at $9.99 (market cap $10.33B), while Hyperliquid Strategies Inc Common Stock trades at $11.55 (market cap $2.32B). The key difference: ImmunityBio Inc. Common Stock is far larger — about 4.5× Hyperliquid Strategies Inc Common Stock's market cap, and ImmunityBio Inc. Common Stock is more actively traded (11,745,198 versus 10,128,727). Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and Hyperliquid Strategies Inc Common Stock for 0 Days on average.
| IBRX | PURR | |
|---|---|---|
Market Cap | $10.33B | $2.32B |
Volume | 11,745,198 | 10,128,727 |
Sector | Health | Financials |
52-Week High | $11.55 | $14.09 |
52-Week Low | $1.98 | $3.10 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $10.79B | $2.18B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →About Hyperliquid Strategies Inc Common Stock
Hyperliquid Strategies is a digital asset treasury company focused on managing a treasury of HYPE tokens, the native digital assets of the Hyperliquid Layer-1 blockchain.
Read more on PURR →
